-+ 0.00%
-+ 0.00%
-+ 0.00%

Puma Biotechnology Sees Q2 Sales $52.000M-$55.000M vs $52.000M Est

Benzinga·05/07/2026 20:30:00
Listen to the news

Second Quarter and Full Year 2026 Financial Outlook

 

Second Quarter

2026

New

Full Year 2026

Prior

Full Year 2026

Net Product Revenue $50–$52 million $202-206 million $194–$198 million
Royalty Revenue $2–$3 million $20–$23 million $20–$23 million
License Revenue $0 $0 $0
Total Revenue $52–$55 million $222-$229 million $214–$221 million
Net Income* $2–$4 million $16-$19 million $10–$13 million
Gross to Net Adjustment 27%–28% 26.5%-27.5% 27.5%–28.5%
       
*The outlook above does not include any potential adjustments for tax valuation allowance